The unpublished study that informed the decision points to a "very small" risk of a complication for certain age groups. Nordic countries are instead recommending the use of Pfizer's vaccine.
The unpublished study that informed the decision points to a "very small" risk of a complication for certain age groups. Nordic countries are instead recommending the use of Pfizer's vaccine.